| Hans-Günter Meyer-Thompson | Hepatitiden
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017.
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017.
Aas CF, Vold JH, Skurtveit S, et al.
BMJ Open. 2020;10(8):e036355. Published 2020 Aug 26. doi:10.1136/bmjopen-2019-036355